Blood sugar rollercoaster in frail seniors: which insulin works best?
NCT ID NCT02486341
First seen Jun 09, 2026 · Last updated Jun 20, 2026 · Updated 3 times
Summary
This study looked at how much blood sugar levels go up and down during the day in frail or disabled patients over 75 with diabetes who use basal insulin. Researchers used a continuous glucose monitor for 5 days to compare two types of insulin: human NPH and long-acting analogues. The goal was to see if one type leads to more stable blood sugar levels, which could help guide better treatment for this vulnerable group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Bordeaux - Xavier Arnozan Hospital
Pessac, 33600, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Insulin (NPH or long-acting analogues)
What this could lead to
If successful, this could help doctors choose the best basal insulin for frail elderly patients to reduce dangerous blood sugar swings.
What could go wrong
This is a small, observational study with only 30 participants, so results may not apply to all older patients. It does not test a new treatment.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.